Major depression and electrovestibulography
- 27 March 2015
- journal article
- research article
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 16 (5) , 334-350
Abstract
Objectives. No electrophysiological neuroimaging or genetic markers have been established that strongly relate to a diagnosis of major depression or its severity. The objective of this paper is to describe the preliminary evaluation of a potential new biomarker for depression utilizing the recording of electrical activity from the outer ear canal referred to as electrovestibulography (EVestG). Methods. Sensory oto-acoustic features were extracted from EVestG data to compare 31 healthy age- and gender-matched individuals as controls to 43 major depressive disorder (MDD) subjects (22 symptomatic (MDD-S), 21 reduced symptomatic (MDD-R)). The stimulus was a single supine-vertical translation. The six features examined were based on the measured firing pattern interval histogram and the shape of the average field potential response. Results. An unbiased classification accuracy of 85, 87 and 77% was achieved for separating Control from MDD-S, Control from MDD, and MDD-S from MDD-R groups respectively. Features used showed low but significant correlations (P < 0.05) with MADRS and CORE assessments. Conclusions. The results support the use of separate features for measuring MDD symptomatology versus diagnosing MDD, representing plausible different mechanisms of brain function in MDD-S and MDD-R. The first evidence of the successful application of sensory oto-acoustic features toward diagnosing and measuring the symptomatology of MDD is presented.Keywords
This publication has 38 references indexed in Scilit:
- Deletion of Glutamate Delta-1 Receptor in Mouse Leads to Aberrant Emotional and Social BehaviorsPLOS ONE, 2012
- The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug DevelopmentThe Scientific World Journal, 2012
- Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implicationsExpert Review of Neurotherapeutics, 2011
- An adenylyl cyclase signaling pathway predicts direct dopaminergic input to vestibular hair cellsNeuroscience, 2010
- The GABAergic deficit hypothesis of major depressive disorderMolecular Psychiatry, 2010
- Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depressionMolecular Psychiatry, 2010
- Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical TrialBiological Psychiatry, 2010
- Neurocircuitry of Mood DisordersNeuropsychopharmacology, 2009
- Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112Neuropsychopharmacology, 2008
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979